Virtus LifeSci Biotech Clinical Trials ETF (BBC) |
| 39.82 0.454 (1.15%) 01-13 15:59 |
| Open: | 39.06 |
| High: | 39.906 |
| Low: | 38.8866 |
| Volume: | 9,920 |
| Market Cap: | 36(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 47.68 |
| Resistance 1: | 40.82 |
| Pivot price: | 38.93 |
| Support 1: | 37.98 |
| Support 2: | 36.22 |
| 52w High: | 40.82 |
| 52w Low: | 13.42 |
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sat, 10 Jan 2026
How Virtus Lifesci Biotech Clinical Trials Etf (BBC) Affects Rotational Strategy Timing - Stock Traders Daily
Fri, 09 Jan 2026
What's Going On With Alumis Stock Thursday? - Sahm
Thu, 08 Jan 2026
What's Going On With Alumis Stock Thursday? - Benzinga
Mon, 29 Dec 2025
(BBC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tue, 23 Dec 2025
Virtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.6554 - MSN
Mon, 01 Dec 2025
Biotech ETF (BBC) Hits New 52-Week High - December 1, 2025 - Zacks Investment Research
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
